11 completed, 4 unknown, 3 terminated, 2 not yet recruiting. 23 Phase 3, 8 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 23 | Completed 11, Unknown 4, Terminated 3, Not yet recruiting 2, Recruiting 2, Active not recruiting 1 |
| Phase 2 | 8 | Completed 6, Not yet recruiting 1, Unknown 1 |
Follow Glucocorticoids: new trials by email Literature Review of Glucocorticoids trials Research Report on Glucocorticoids
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Autologous Circulating Extracellular Vesicles for Total-Type Sudden Sensorineural Hearing Loss autologous circulating extracellular vesicles, Glucocorticoids - Sudden Sensorineural Hearing Loss (SSNHL) | Phase 3 | Not yet recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 146 | 2026-09-15 | 2026-10-16 |
| A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With Vacuoles, E1-enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome Momelotinib, Glucocorticoids, Placebo - VEXAS Syndrome | Phase 2 / Phase 3 | Not yet recruiting | GlaxoSmithKline | 136 | 2026-08-05 | 2026-06-01 |
| A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease Rilzabrutinib, Placebo, Glucocorticoid - Immunoglobulin G4 Related Disease | Phase 3 | Recruiting | Sanofi | 124 | 2025-09-26 | 2026-10-20 |
| OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study) Obinutuzumab, CTX combined with Glucocorticoids - Primary Membranous Nephropathy | Phase 3 | Recruiting | Huashan Hospital | 144 | 2024-10-23 | 2026-01-21 |
| A Trial to Learn More About an Experimental Gene Therapy Called Bidridistrogene Xeboparvovec (SRP-9003) as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4 SRP-9003, Glucocorticoid - Limb-girdle Muscular Dystrophy | Phase 3 | Active not recruiting | Sarepta Therapeutics, Inc. | 17 | 2024-01-15 | 2026-03-02 |
| Effectiveness of Probiotics in Patients of Mild to Moderate Rheumatoid Arthritis probiotic plus standard treatment, standard treatment - Rheumatoid Arthritis | Phase 3 | Completed | King Edward Medical University | 88 | 2023-08-24 | 2024-09-19 |
| Sinomenine Versus Glucocorticoid for Knee OA Sinomenine, Glucocorticoid - Knee Osteoarthritis | Phase 3 | Unknown | Shanghai 6th People's Hospital | 328 | 2023-02-28 | 2023-03-10 |
| A Study With Imlifidase in Anti-GBM Disease Imlifidase, Plasma exchange (PLEX), Cyclophosphamide (CYC) - Anti-Glomerular Basement Membrane Disease, Anti-Glomerular Basement Membrane Antibody Disease | Phase 3 | Terminated | Hansa Biopharma AB | 50 | 2022-12-22 | 2026-03-04 |
| Study of Therapeutic Value of Periorbital Injection of Glucocorticoid in Mild TAO Glucocorticoids - Thyroid Associated Ophthalmopathy | Phase 3 | Unknown | Sun Yat-sen University | 142 | 2021-05-01 | 2021-05-18 |
| A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE) Tocilizumab Prefilled Syringe [Actemra], Placebos, Glucocorticoids - Polymyalgia Rheumatica | Phase 3 | Completed | Medical University of Vienna | 39 | 2017-11-24 | 2021-01-22 |
| Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis MMF, CYC, Glucocorticoids - Takayasu Arteritis | Phase 3 | Completed | Chinese SLE Treatment And Research Group | 138 | 2017-03-16 | 2023-08-30 |
| A Study Evaluating Vitamin D in Allergic Bronchopulmonary Aspergillosis Complicating Asthma Glucocorticoids, Vitamin D - Allergic Bronchopulmonary Aspergilloses | Phase 2 / Phase 3 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 30 | 2016-12-01 | 2018-08-23 |
| Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate Monotherapy Methotrexate, Leflunomide, Hydroxychloroquine - Rheumatoid Arthritis | Phase 3 | Terminated | Jawaharlal Institute of Postgraduate Medical Education & Research | 136 | 2016-09-01 | 2021-07-27 |
| A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis Itraconazole, Glucocorticoids - Allergic Bronchopulmonary Aspergillosis | Phase 2 / Phase 3 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 191 | 2014-05-01 | 2022-10-07 |
| The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach 5 mg prednisone, 0 mg prednisone - Granulomatosis With Polyangiitis, Wegener Granulomatosis | Phase 3 | Unknown | University of South Florida | 12 | 2014-02-17 | 2024-07-29 |
| The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach 5 mg Prednisone, 0 mg Prednisone - Granulomatosis With Polyangiitis | Phase 3 | Completed | University of Pennsylvania | 159 | 2014-02-01 | 2026-08-06 |
| Diagnostic Value of Oral Prednisolone Test for Rheumatoid Arthritis Prednisolone - Rheumatoid Arthritis | Phase 2 / Phase 3 | Completed | Rheumazentrum Ruhrgebiet | 130 | 2012-02-01 | 2015-05-18 |
| Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host Disease Biological: mesenchymal stem cell, Cyclosporine and Glucocorticoid - Chronic Graft Versus Host Disease | Phase 2 / Phase 3 | Unknown | Chinese Academy of Medical Sciences | 100 | 2012-02-01 | 2012-08-03 |
| Clinical Study Comparing the New Immunosuppressive Drug Gusperimus With the Conventional Treatment in Wegener's Granulomatosis Gusperimus + glucocorticoids, cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids - Wegeners Granulomatosis | Phase 3 | Terminated | Nordic Pharma SAS | 4 | 2011-11-01 | 2015-05-29 |
| Monotherapy of Itraconazole Versus Prednisolone in Allergic Bronchopulmonary Aspergillosis Glucocorticoids, Itraconazole - Allergic Bronchopulmonary Aspergillosis | Phase 2 / Phase 3 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 100 | 2011-04-01 | 2017-03-16 |
Showing 20 of 23. Sign in to see all of them.
Aspergillosis, Allergic Bronchopulmonary (4) · Granulomatosis with Polyangiitis (4) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (3) · Arthritis, Rheumatoid (3) · Vasculitis (3) · Anti-Glomerular Basement Membrane Disease (1) · Asthma (1) · Bronchiolitis Obliterans Syndrome (1) · Cardiovascular Diseases (1) · Disease (1) · Graves Ophthalmopathy (1) · Hearing Loss, Sudden (1) · Heart Failure (1) · Hypersensitivity (1) · Immunoglobulin G4-Related Disease (1)
Post Graduate Institute of Medical Education and Research, Chandigarh (4) · University of Pennsylvania (2) · Chinese Academy of Medical Sciences (1) · Chinese SLE Treatment And Research Group (1) · GlaxoSmithKline (1) · Hansa Biopharma AB (1) · Hebei Medical University (1) · Huashan Hospital (1) · Jawaharlal Institute of Postgraduate Medical Education & Research (1) · King Edward Medical University (1) · Medical University of Vienna (1) · Nordic Pharma SAS (1) · Rheumazentrum Ruhrgebiet (1) · Sanofi (1) · Sarepta Therapeutics, Inc. (1)
China (7) · United States (6) · India (5) · Belgium (4) · Germany (4) · Italy (4) · United Kingdom (4) · Canada (3) · Czechia (3) · France (3) · Spain (3) · Sweden (3) · Austria (2) · Denmark (2) · Japan (2)
David Jayne, MD (2) · Peter A Merkel, MD, MPH (2) · Ritesh Agarwal, MD, DM (2) · Chunhua Zhao, MD,PHD (1) · Gulraiz Iqbal, MBBS (1) · Haidi Yang, Doctor (1) · He Huang, MD (1) · Huasheng Yang, Doctor (1) · Jeffery P Krischer, PhD (1) · Jeffrey P Krischer, PhD (1) · Juergen Braun, MD (1) · Kunshen Liu, MD (1)
PMID 39425055, PMID 10068416, PMID 16221103, PMID 17332971, PMID 20054700, PMID 26585431, PMID 27924855, PMID 28246067, PMID 28388956, PMID 29331473, PMID 30561849, PMID 32053298, PMID 34586472, PMID 35210264, PMID 36155131, PMID 38346237, PMID 41560786
2025 (2), R01HL115041 (2), 2009 (1), 2016 (1), U54AR057319 (1)